Sustaining weight loss is rarely as simple as eating less and working out more. In fact, the key may actually be rooted in ...

New research suggests the weight-loss medications could be powerful tools in tackling substance use disorders.

In a recent review, a small group of patients received the injections less frequently but still maintained weight loss and health benefits.

Feb 26 (Reuters) - Eli Lilly's experimental weight-loss pill, orforglipron, caused more side effects and treatment ...

A November 2025 Kaiser Family Foundation poll found that 1 in 8 U.S. adults have tried a GLP-1 medication for weight loss, diabetes or another condition. And we expect that number to rise now that one ...

A year after stopping taking weight loss drugs such as Ozempic and Wegovy, people regain, on average, 60% of their lost ...

Originally developed for Type 2 diabetes, GLP-1 drugs like Ozempic and Wegovy prolong natural satiety signals, extending the ...

Researchers have hailed a new once-a-day weight loss pill as an “important advancement” in type 2 diabetes care. A new study ...

The proportion of participants achieving HbA1c < 7.0% and a ≥10% reduction in body weight from baseline was 48.0% in the mazdutide group and 21.0% in the semaglutide group DREAMS-3 is the world's ...

Novo’s CagriSema shot was shown to be less effective than rival Lilly’s tirzepatide ...